ALK-inhibitors as a novel potential therapy for proteasome inhibitor-resistant multiple myeloma

被引：0
作者：
Besse, Lenka
Besse, Andrej
Kraus, Marianne
Jasik, Matej
Slaby, Ondrej
Driessen, Christoph
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2851
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2851
引用
收藏
页数：2
相关论文
共 50 条
[41]   Proteasome inhibitors in the treatment of multiple myeloma [J].
Shah, J. J. ;
Orlowski, R. Z. .
LEUKEMIA, 2009, 23 (11) :1964-1979
[42]   PROTEASOME INHIBITORS FOR USE IN MULTIPLE MYELOMA [J].
Jain, S. ;
Satija, N. .
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2014, 5 (02) :320-329
[43]   SIX YEAR RESULTS OF THE THERAPY OF MULTIPLE MYELOMA INTRACELLULAR PROTEASOME INHIBITOR [J].
Skvortsova, N. ;
Pospelova, T. ;
Nechunaeva, I. .
HAEMATOLOGICA, 2013, 98 :614-614
[44]   Towards Better Proteasome Inhibitor-Based Therapy in Multiple Myeloma [J].
Voorhees, Peter .
ONCOLOGIST, 2012, 17 :9-9
[45]   Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma [J].
Chen J.H. ;
Lenihan D.J. ;
Phillips S.E. ;
Harrell S.L. ;
Cornell R.F. .
Cardio-Oncology, 3 (1)
[46]   TYROSINE KINASE INHIBITORS POTENTIATE ANTI-MYELOMA ACTIVITY OF PROTEASOME INHIBITOR CARFILZOMIB IN RESISTANT MULTIPLE MYELOMA CELL LINES AND PATIENT SAMPLES [J].
Ao, Lin ;
Lee, Wooin ;
Kim, Kyung-Bo .
DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) :S50-S50
[47]   The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma [J].
Brayer, Jason ;
Baz, Rachid .
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2017, 8 (07) :209-220
[48]   Oral proteasome inhibitor maintenance for multiple myeloma [J].
van de Donk, Niels W. C. J. ;
Yong, Kwee .
LANCET, 2019, 393 (10168) :204-205
[49]   First proteasome inhibitor approved for multiple myeloma [J].
Twombly, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :845-845
[50]   Proteasome inhibitor bortezomib for the treatment of multiple myeloma [J].
Cavo, M. .
LEUKEMIA, 2006, 20 (08) :1341-1352
12345